Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023)
Ginkgo Bioworks Holdings (DNA) posted Change in Inventory of -$694000.0 for Q2 2023, up 62.59% on a QoQ basis from -$1.9 million in Q1 2023, and down 16.64% year-over-year from -$832520.2 in Q2 2022.
Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings' Change in Inventory history runs 4 years deep, the most recent figure standing at -$694000.0 for Q2 2023.
- Quarterly Change in Inventory fell 16.64% year-over-year to -$694000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$7.5 million (down 238.38% YoY) and the FY2022 annual result came in at -$164000.0, down 126.2% from the prior year.
- Change in Inventory was -$694000.0 for Q2 2023 at Ginkgo Bioworks Holdings, up from -$1.9 million in the prior quarter.
- Across five years, Change in Inventory topped out at $5.3 million in Q1 2022 and bottomed at -$2.7 million in Q4 2022.
- A 4-year average of -$15454.5 and a median of -$595000.0 in 2022 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 683.41% in 2022, while the deepest fall reached 2276.79% in 2022.
- Ginkgo Bioworks Holdings' Change in Inventory stood at $1.9 million in 2020, then sank by 105.84% to -$112000.0 in 2021, then plunged by 2276.79% to -$2.7 million in 2022, then soared by 73.93% to -$694000.0 in 2023.
- Business Quant data shows DNA's Change in Inventory at -$694000.0 in Q2 2023, -$1.9 million in Q1 2023, and -$2.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -694,000.00 |
| Jun 30, 2023 | -694,000.00 |
| Mar 31, 2023 | -1.86 Mn |
| Mar 31, 2023 | -1.86 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Jun 30, 2022 | -595,000.00 |
| Jun 30, 2022 | -595,000.00 |
| Mar 31, 2022 | 5.34 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | -112,000.00 |
| Dec 31, 2021 | -112,000.00 |
| Sep 30, 2021 | 758,000.00 |
| Sep 30, 2021 | 758,000.00 |
| Jun 30, 2021 | -701,000.00 |
| Jun 30, 2021 | -701,000.00 |
| Mar 31, 2021 | 681,000.00 |
| Mar 31, 2021 | 681,000.00 |